South Korea-based medical AI company Coreline Soft and Mint Medical have announced a partnership to advance AI-enabled lung cancer screening workflows.
Following more than six months of technical integration work, Coreline Soft's AVIEW imaging platform has been integrated into Mint Lesion, Mint Medical's structured reporting and imaging data management platform, according to an announcement. The integration is designed to support an end-to-end screening workflow connecting AI-powered pulmonary nodule detection, structured reporting, longitudinal nodule tracking, and multisite reading management, the companies said.
The partnership is initially focused on Germany, where low-dose CT-based lung cancer screening entered statutory health insurance reimbursement in April 2026 and national standards require double reading, CAD software utilization, and longitudinal follow-up, the companies noted.
The companies said the collaboration is designed to scale across international markets with similar screening programs.



















